Author:
Giamarellou H.,Tsagarakis J.,Petrikkos G.,Daikos G. K.
Publisher
Springer Science and Business Media LLC
Subject
Microbiology (medical),Microbiology,Infectious Diseases,Microbiology (medical),General Medicine
Reference7 articles.
1. Downs, J., Andriole, V. T., Ryan, J. L.: In vitro activity of MK-0366 against clinical urinary pathogens, including gentamicin-resistantPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1982, 21: 670–672.
2. Ito, A., Hirai, K., Inone, M., Koga, H., Suzue, S., Irijura, I., Misuhashi, S.: In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrobial Agents and Chemotherapy 1980, 17: 103–108.
3. King, A., Warren, C., Shannon, K., Phillips, I.: In vitro antibacterial activity of norfloxacin (MK-0366). Antimicrobial Agents and Chemotherapy 1982, 21: 604–607.
4. Thomas, V., Shelokov, A., Forland, M.: Antibodycoated bacteria in the urine and site of urinary tract infection. New England Journal of Medicine 1974, 290: 588–590.
5. Washington, J. A., Sutter, V. L.: Dilution susceptibility test: agar and macro-broth dilution procedures. In: Lennette, E. H., Balows, A., Hausler, W. J., Truant, J. P. (ed.): Manual of clinical microbiology. American Society for Microbiology, Washington, D.C., 1980, p. 453–458.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献